Delivery Order SPE2DB22D2214-SPE2DB25FS6AJ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion in 30-unit quantities, valued at $1,068.57. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is scheduled for ultimate completion by July 21, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a $7,327.31 delivery order to AmerisourceBergen Drug Corp for Cyclosporine 0.05% Eye Emulsion (30-count packages) on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply transaction under the company's broader federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion in 30-unit quantities, with a ceiling value of $6,435.48 and a firm fixed price structure. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion in 30-count units, valued at $3,558.39. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award eligibility. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a $1,216.72 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion in 60-unit packaging. This is a firm fixed-price delivery order with an ultimate completion date of July 24, 2025, utilizing no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs. The...
- The Defense Logistics Agency awarded a $1,342.35 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Cyclosporine 0.05% Eye Emulsion (30-count units). This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The contract specifies a place of performance in Conshohocken, Pennsylvania, AmerisourceBergen's corporate headquarters, with an ultimate completion date of July 25, 2025. This delivery order...
- This delivery order awards $1,045.92 to AmerisourceBergen Drug Corp for the supply of Cyclosporine 0.05% Eye Emulsion in 30-unit quantities under a firm fixed price contract. The award was issued on August 4, 2025, with an ultimate completion date of August 5, 2025, and represents a non-competitive, non-set-aside procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Cyclosporine 0.05% eye emulsion. The contract, which is a firm fixed-price delivery order, has a ceiling value of $1,465.16 and a completion date of July 10, 2025. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Cyclosporine 0.05% Eye Emulsion, a prescription medication, with a ceiling value of $2,741.60 and a period of performance through June 24, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,432.00 contract is for the supply of Cyclosporine 0.05% eye emulsion, a specialty pharmaceutical product, to support military treatment programs and facilities. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB25FS6AJDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for Cyclosporine 0.05% Eye Emulsion in 30-unit quantities, with a ceiling value of $3,975.87. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement through open competition. The product will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. The prime IDC enables the contractor to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide, including specialty medications, generic drugs, vaccines, and medical supplies across multiple therapeutic domains. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp serves diverse customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 8/4/25 |